NCT04581135View on ClinicalTrials.gov

Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19

CompletedOBSERVATIONAL
Enrollment

620

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

January 30, 2022

Study Completion Date

January 30, 2022

Conditions
COVID-19
Interventions
OTHER

COVID-19

Research project in which biological material is sampled and health-related personal data are collected and used for further research. Coded data are used.

Trial Locations (9)

1011

CHUV - Service de Pneumologie, Lausanne

1211

Hôpitaux Universitaires de Genève - Service de Pneumologie, Geneva

1708

University and Hospital of Fribourg, Fribourg

1950

Hôpital du Valais - Service de Pneumologie, Sion

3010

Universtiy Hospital Bern (Inselspital), Department of Pulmonary Medicine - Lead Center, Bern

4002

St. Claraspital AG - Department of Pulmonary Medicine, Basel

6900

Clinica Moncucco, Lugano

8091

Universitätsspital Zürich - Klinik für Pneumologie, Zurich

9007

Kantonspital St. Gallen - Klinik für Pneumologie und Schlafmedizin Lungenzentrum, Sankt Gallen

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT04581135 - Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19 | Biotech Hunter | Biotech Hunter